Magrath George 4

4 · Opus Genetics, Inc. · Filed Mar 18, 2026

AI-generated summary of this filing

Updated Mar 18, 2026

Opus Genetics (IRD) CEO Magrath George Sells 24,438 Shares

What Happened

Magrath George, CEO of Opus Genetics, sold 24,438 shares on 2026-03-16 at a weighted average price of $5.21 per share, generating approximately $127,327 in proceeds. The sale was automatic to satisfy tax withholding obligations tied to the vesting and settlement of a restricted stock unit (RSU) award and was not a discretionary trade by the CEO.

Key Details

Transaction date: 2026-03-16; Form 4 filed: 2026-03-18.
Transaction type/code: Sale (S); reason: tax withholding for RSU settlement (footnote F1).
Price: Weighted average $5.21; shares sold in multiple transactions at prices ranging $5.21 to $5.215 (footnote F2).
Total proceeds reported: ~$127,327.
Shares owned after transaction: Not specified in the provided filing.
Timeliness: Filed two days after the transaction; no late-filing flag indicated.

Context

This was a routine tax-withholding sale related to RSU vesting (often coded F), which is administrative and does not necessarily reflect the insider's market view. The filer offered to provide a per-trade breakdown of the shares sold at each price within the reported range upon request.

Form 4

Period: 2026-03-16

DirectorChief Executive Officer

Transactions

Footnotes (2)

[F1]The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person.
[F2]The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.21 to $5.215, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Signature

/s/ Amy Rabourn, by Power of Attorney|2026-03-18

1 file